NASDAQ:MACK
Merrimack Pharmaceuticals, Inc.
- Stock
Last Close
15.12
15/05 15:59
Market Cap
189.75M
Beta: 1.80
Volume Today
169.53K
Avg: 70.31K
PE Ratio
−152.04
PFCF: −135.35
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 47.79M - | 102.76M 115.03% | 89.26M 13.14% | 144.27M 61.64% | ||||||||
cost of revenue | 46K - | 6.91M 14,926.09% | 2.23M - | 445K - | ||||||||
gross profit | 47.79M - | 102.76M 115.03% | 89.21M 13.18% | 137.36M 53.97% | -2.23M - | -445K - | ||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 21.19M - | 30.52M 44.04% | 28.45M - | 15.60M 45.17% | 16.17M 3.64% | 5.01M 69.00% | 2.62M 47.81% | 2.17M 16.90% | 2.18M 0.09% | |||
selling general and administrative expenses | 21.19M - | 30.52M 44.04% | 57.59M 88.73% | 80.73M 40.17% | 28.45M 64.76% | 15.60M 45.17% | 16.17M 3.64% | 5.01M 69.00% | 2.62M 47.81% | 2.17M 16.90% | 2.18M 0.09% | |
research and development expenses | 147.14M - | 138.50M 5.87% | 160.99M 16.24% | 160.92M 0.04% | 67.31M 58.17% | 49.97M 25.76% | 11.10M 77.79% | |||||
other expenses | -10.14M - | -17.30M 70.56% | -18.22M 5.28% | -43.38M 138.13% | -1.43M 96.70% | -3.23M 125.40% | 370K 111.46% | -191K 151.62% | ||||
cost and expenses | 168.33M - | 169.01M 0.41% | 218.63M 29.36% | 248.56M 13.69% | 95.77M 61.47% | 65.58M 31.53% | 27.27M 58.42% | 5.01M 81.62% | 2.62M 47.81% | 2.17M 16.90% | 2.18M 0.09% | |
operating expenses | 168.33M - | 169.01M 0.41% | 218.58M 29.33% | 241.65M 10.55% | 95.77M 60.37% | 65.58M 31.53% | 27.27M 58.42% | 5.01M 81.62% | 2.62M 47.81% | 2.17M 16.90% | 2.18M 0.09% | |
interest expense | 10.94M - | 18.23M 66.67% | 19.23M 5.50% | 43.65M 126.94% | 34.65M 20.61% | 956K 97.24% | 1.53M 59.83% | -188K - | ||||
ebitda | -120.54M - | -66.26M 45.03% | -129.37M 95.26% | -98.43M 23.92% | -91.08M 7.46% | -63.43M 30.36% | -23.89M 62.33% | -5.15M 78.43% | -2.76M 46.44% | -2.62M 5.11% | -2.18M 16.91% | |
operating income | -120.54M - | -66.26M 45.03% | -129.57M 95.56% | -110.14M 15.00% | -95.77M 13.05% | -65.58M 31.53% | -22.36M 65.90% | -2.87M 87.15% | -2.47M 13.96% | -1.73M 30.06% | -2.18M 25.85% | |
depreciation and amortization | 2.59M - | 3.22M 24.49% | 4.29M 33.04% | 6.25M 45.73% | 5.22M 16.45% | 4.07M 21.97% | -1.53M 137.68% | -2.28M 48.53% | -288K 87.37% | -890K 209.03% | ||
total other income expenses net | -10.14M - | -17.30M 70.56% | -18.22M 5.28% | -49.23M 170.27% | 11.12M 122.58% | -3.23M 129.05% | -381K 88.20% | -141K 62.99% | 20K 114.18% | 188K 840% | 1.01M 435.64% | |
income before tax | -130.69M - | -83.56M 36.06% | -147.79M 76.87% | -153.52M 3.88% | -118.40M 22.87% | -68.46M 42.18% | -22.74M 66.78% | -3.01M 86.75% | -2.45M 18.65% | -1.54M 37.15% | -1.17M 24.14% | |
income tax expense | -2.35M - | -3.49M 48.62% | -3.92M 12.23% | -13.22M 237.52% | -42.40M 220.62% | -7.70M 81.85% | -1.47M 80.86% | 14K 100.95% | 3K 78.57% | 3K 0% | 12K 300% | |
net income | -130.93M - | -83.29M 36.38% | -147.96M 77.64% | -151.74M 2.56% | 472.03M 411.08% | -40.51M 108.58% | -21.27M 47.50% | -3.03M 85.76% | -2.46M 18.92% | -1.54M 37.11% | -1.18M 23.51% | |
weighted average shs out | 9.89M - | 10.44M 5.55% | 11.14M 6.65% | 12.53M 12.55% | 13.23M 5.58% | 13.34M 0.84% | 13.35M 0.07% | 13.38M 0.20% | 13.41M 0.20% | 13.52M 0.87% | 14.30M 5.73% | |
weighted average shs out dil | 9.89M - | 10.44M 5.55% | 11.14M 6.65% | 12.53M 12.55% | 13.23M 5.58% | 13.34M 0.84% | 13.35M 0.07% | 13.38M 0.20% | 13.41M 0.20% | 13.52M 0.87% | 14.30M 5.73% | |
eps | -13.24 - | -7.98 39.73% | -13.29 66.54% | -12.11 8.88% | 35.67 394.55% | -3.04 108.52% | -1.59 47.70% | -0.23 85.53% | -0.18 21.74% | -0.11 38.89% | -0.08 24.91% | |
epsdiluted | -13.24 - | -7.98 39.73% | -13.29 66.54% | -12.11 8.88% | 35.67 394.55% | -3.04 108.52% | -1.59 47.70% | -0.23 85.53% | -0.18 21.74% | -0.11 38.89% | -0.08 24.91% |
All numbers in USD (except ratios and percentages)